Ranbaxy
Ranbaxy Introduces Glaxo's Valacyclovir to American Market
Submitted by Tangaroa Snell on Fri, 11/27/2009 - 06:43
In a new development, medical giant Ranbaxy has taken popular drug Valacyclovir hydrochloride, which is the generic version of GlaxoSmithKline's Valtrex, to markets across US. The pharmaceutical company takes the drug to US on November 25, and it is expected to net nearly $200 Million in revenue during the initial 6 months exclusive period.
Good News USA
Entertainment News
- Music blogging network MOG raises $9.5 million in new funding round
- Ticketmaster Agrees to Pay Refunds for Deceiving Ticket Sales
- CBS chief: NBC’s failed Leno experiment brought increased ad revenue for CBS
- Walt Disney unveils its new ‘KeyChest’ “enabling technology”
- Rotten Tomatoes Sold to Flixster by News Corp